AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
48.38
+0.41 (0.85%)
Nov 10, 2026, 4:00 PM EST - Market closed
AnaptysBio Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, AnaptysBio stock has a consensus rating of "Strong Buy" and an average price target of $87.25. The average 1-year stock price forecast is 80.34% higher than the current stock price, while the lowest is $60 (+24.02%) and the highest is $140 (+189.38%).
Price Target: $87.25 (+80.34%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AnaptysBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 → $95 | Buy | Reiterates | $52 → $95 | +96.36% | Oct 26, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $81 | Buy | Maintains | $81 | +67.42% | Oct 22, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $70 → $60 | Buy | Reiterates | $70 → $60 | +24.02% | Sep 30, 2026 |
| Barclays | Barclays | Buy Maintains $75 | Buy | Maintains | $75 | +55.02% | Sep 23, 2026 |
| UBS | UBS | Buy Reiterates $76 | Buy | Reiterates | $76 | +57.09% | Sep 22, 2026 |
Financial Forecast
Revenue This Year
101.12M
from 234.60M
Decreased by -4.69%
Revenue Next Year
171.31M
from 106.09M
Increased by 69.42%
EPS This Year
4.20
from -0.46
EPS Next Year
4.54
EPS and Forward PE are based on non-GAAP adjusted numbers.